GH Research PLC

GHRS Stock Healthcare Biotechnology
$27.36
+0.38 (+1.41%)
Price as of Sep 01, 2026 market close

Performance

1 Month
-2.9%
3 Months
+10.0%
YTD
+115.4%
1 Year
+102.7%

Price return, based on split- and dividend-adjusted closing prices.

Risk

Volatility 1-year annualized
72.6%
Largest decline max drawdown, since Aug 2025
-27.4%
Risk-adjusted return Sharpe ratio, 1-year
1.32

Own GHRS?

See how GHRS contributes to your portfolio's return, allocation, and risk.

7-day free trial, then $9/month.